An Anavex Veterinary Role Not Yet Considered
Yes, consider, if you will, a reversed development of Anavex 2-73. Humans to animals.
Virtually all drugs being proposed for human use are first tested on animals, usually lab rats and mice, testing for both safety and efficacy. Without such animal testing, without positive animal outcomes, no subsequent human testing is allowed or performed. Understood — because the biological mechanisms and chemical pathways of lab animals very much parallel those of humans.
Because of that, the paralleled animal/human similarities, what prohibits the use of new drugs targeted at humans back into animals? What is the chance that Anavex 2-73 (or other Anavex pipeline drug) might have a useful application for veterinary uses in farm animals?
Might it be discovered that Anavex 2-73 fed to feedlot cattle reduces anxieties, increases sleep quality, or inhibits various pathologies of close confinement; any of which thereby increases growth?
As I implied in my earlier posting on this, lab techs dosing and caring for lab murines dosed with Anavex 2-73 must accurately and precisely monitor and record all behaviors. Should Anavex 2-73 have induced any incidental, albeit peripheral good health benefits to any of those lab rats or mice, it would be noted and further investigated.
What if Anavex 2-73, incidentally, slowed aging and maintained reproductive abilities for longer periods of time. What if those dosed lab rats had better metabolism of their food? If any of this were so, then next start dosing feeder cattle in confined feedlots, or chickens in hatcheries and poult-production facilities. If production increases in any way, with no residual molecules or metabolites in derived market eggs or meat, Anavex Life Sciences Corp has a many billions of dollars new market segment.
In a few years, could Anavex Life Sciences Corp, or a spin-off, be a major veterinary drug supplier?
News 
Market Data 
Discover 
